Enhanced Methods and Apparatuses for Reducing Bleeding via Coordinated Trigeminal and Vagal Nerve Stimulation

This inventive concept discloses advanced methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation, offering improved safety, efficiency, and real-time adaptability.

The original patent addressed the need for preventing and/or treating bleeding in a subject. However, it had limitations in terms of stimulation frequency, platelet activity monitoring, and real-time feedback. This inventive concept solves these problems by integrating sensors, neural interfaces, and real-time feedback mechanisms to optimize bleed time reduction.

The enhanced system comprises a wearable apparatus with at least two electrodes and a controller for generating electrical pulses. The system further includes a sensor for monitoring blood platelet activity and adjusting the stimulation frequency in real-time to optimize bleed time reduction. Additionally, the system can administer a platelet-activating agent to enhance the stimulation's effect on bleed time reduction. The neural interface provides real-time feedback on the patient's neural response to the stimulation, allowing for precise adjustments. The controller generates electrical pulses tailored to the patient's specific bleed time profile, and the neural stimulator applies the electrical pulses to both the trigeminal nerve and the vagus nerve, adjusting the pulse frequency and amplitude based on the patient's real-time bleed time data.

The new claims introduce novel features such as real-time platelet activity monitoring, neural interface feedback, and tailored stimulation pulses, which are not present in the original patent. These advancements provide a significant improvement in bleed time reduction, safety, and efficiency, making the inventive concept non-obvious and novel compared to the original patent.

Alternative embodiments of the inventive concept could include using different types of sensors, such as optical or electrochemical sensors, to monitor platelet activity. Variations could also include using different neural interfaces, such as electroencephalography (EEG) or functional near-infrared spectroscopy (fNIRS), to provide real-time feedback. Additionally, the system could be adapted for use in different medical settings, such as emergency response or surgical procedures.

The enhanced methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation have significant commercial potential in the medical device industry, particularly in the fields of emergency medicine, surgery, and wound care. The target market includes hospitals, emergency response services, and medical device manufacturers.